Skip to main content
OpenTrials

Clinical trial condition

Eye Diseases

Explore clinical trials studying Eye Diseases. Study availability and eligibility vary by location and protocol.

10,671 public trials 1,320 recruiting studies
Refine in advanced search Browse all conditions

Eye Diseases trial results

Active, not recruiting

Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy

NCT06018558

Conditions
Eye Diseases, Geographic Atrophy, Macular Degeneration, +2 more
Locations
  • Associated Retina Consultants Phoenix, Arizona, United States
  • Advanced Research, LLC Coral Springs, Florida, United States
  • Miidwest Eye Institute Carmel, Indiana, United States
  • Mississippi Retina Associates Jackson, Mississippi, United States
View Trial Details
Active, not recruiting

Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber Congenital Amaurosis

NCT05203939

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Enhanced S-Cone Syndrome, Eye Diseases, +9 more
Locations
  • Associated Retina Consultants Phoenix, Arizona, United States
  • Ocugen Site 5 - University of California, San Diego (UCSD) - Shiley Eye Institute La Jolla, California, United States
  • Ocugen Site 3 - Bascom Palmer Eye Institute Miami, Florida, United States
  • Ocugen Site 6 - Emory University Atlanta, Georgia, United States
View Trial Details
Active, not recruiting

Automated Imaging Differentiation of Parkinsonism

NCT05913687

Conditions
Autonomic Nervous System Diseases, Basal Ganglia Diseases, Brain Diseases, +21 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California San Diego La Jolla, California, United States
  • University of California San Francisco San Francisco, California, United States
  • University of Florida Gainesville, Florida, United States
View all 21 locations
View Trial Details
Active, not recruiting

The A.R.R.E.S.T.® Contact Lens Study

NCT06878118

Conditions
Eye Diseases, Myopia, Myopia Progression, +1 more
Locations
  • Wenzhou Medical University Wenzhou, Zhejiang, China
  • Optometry Clinic, Faculty of Health Science, Universiti Kebangsaan Malaysia Kuala Lumpur, Malaysia
View Trial Details
Active, not recruiting

A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease

NCT05956626

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +5 more
Locations
  • Associated Retina Consultants Phoenix, Arizona, United States
  • Retinal Consultants Medical Group Sacramento, California, United States
  • Vitreo Retinal Associates, P.A. Gainesville, Florida, United States
  • Bascom Palmer Eye Institute Miami, Florida, United States
View all 14 locations
View Trial Details
Active, not recruiting

A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa

NCT06388200

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +5 more
Locations
  • Associated Retina Consultants Phoenix, Arizona, United States
  • University of Southern Califormia La Jolla, California, United States
  • University of Southern California, Roski Eye Insitute Los Angeles, California, United States
  • Advanced Research, LLC. Deerfield Beach, Florida, United States
View all 17 locations
View Trial Details
Active, not recruiting

A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma

NCT06007690

Conditions
Choroidal Melanoma, Eye Diseases, Eye Neoplasms, +14 more
Locations
  • UCSD Shiley Eye Institute, Jacobs Retina Center La Jolla, California, United States
  • Doris Stein Eye Research Center Los Angeles, California, United States
  • Stanford University School of Medicine Palo Alto, California, United States
  • Retinal Consultants Medical Group, Inc. Sacramento, California, United States
View all 66 locations
View Trial Details
Active, not recruiting

Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)

NCT06912633

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +5 more
Locations
  • Associated Retina Consultants Phoenix, Arizona, United States
  • California Retina Consultants Bakersfield, California, United States
  • Retina-Vitreous Associates Medical Group Beverly Hills, California, United States
  • Gavin Herbert Eye Institute, UC Irvine Irvine, California, United States
View Trial Details
Active, not recruiting

Optimal Treatment Protocol for Selective Laser Trabeculoplasty

NCT03798223

Conditions
Exfoliation Syndrome, Eye Diseases, Glaucoma, +5 more
Locations
  • Ogonkliniken, Sodra Alvsborgs Sjukhus Borås, Västra Götaland County, Sweden
  • Ogonkliniken, Sahlgrenska Universitetssjukhuset Mölndal, Västra Götaland County, Sweden
  • Ogonkliniken, Skaraborgs Sjukhus Skövde, Västra Götaland County, Sweden
  • Ogonkliniken NU-sjukvarden Uddevalla, Västra Götaland County, Sweden
View Trial Details
Active, not recruiting

Optilume™ BPH Catheter System in Men With Symptomatic BPH

NCT04131907

Conditions
Benign Prostatic Hyperplasia, Color Vision Defects, Cone Dystrophy, +14 more
Locations
  • Arkansas Urology Little Rock, Arkansas, United States
  • Colorado Clinical Research Golden, Colorado, United States
  • Advanced Urology Institute Daytona Beach, Florida, United States
  • Florida Urology Partners Tampa, Florida, United States
View all 21 locations
View Trial Details

Related conditions